BEKE stock fell 1.17 percent as RSU grant entered the filing trail

Published on 10/04/2026 at 14:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

KE Holdings approved 471,120 RSUs for 15 employees on October 1. Q2 revenue reached USD 3.61 billion and EPS topped USD 0.31 consensus.

BEKE, US4824971042, Illustration mit AI erstellt.

BEKE stock (ISIN US4824971042) fell 1.17 percent to USD 16.44 on the NYSE on October 2, 2026, with 3,930,153 shares traded. The latest filing adds a corporate action to the picture: KE Holdings approved 471,120 restricted share units for 15 employees on October 1, 2026, according to StockTitan.

471,120 RSUs enter the filing

The awards remain subject to employee acceptance and have a nil purchase price. The filing states that the grants carry no performance targets and will vest in schedules running from 24 to 48 months, making the October 1 action an incentive measure rather than an operating forecast.

The grant is linked to Class A ordinary shares registered in the depositary bank's name. As of September 30, 2026, 120,391,976 awards could still be granted under the 2020 Share Incentive Plan, subject to awards that lapse or are forfeited, StockTitan reports.

Q2 profit beat the consensus

The more important operating checkpoint came with the 2026 second quarter results released on August 21. KE Holdings reported USD 3.61 billion in revenue against USD 3.59 billion expected, while EPS reached USD 0.42 versus USD 0.31 consensus, according to MarketBeat.

That combination puts the filing in a wider context. Revenue exceeded the published estimate by USD 20 million, while EPS was USD 0.11 above consensus, but the share price still finished lower on October 2. For investors, the contrast is between stronger earnings delivery and a stock trading below the analyst target range.

Consensus target stays above USD 23

MarketBeat's October 3, 2026 page lists a Buy consensus based on 8 analysts, with a high target of USD 26.00, a low target of USD 21.00 and an average target of USD 23.64. The average target lies 43.8 percent above the USD 16.44 NYSE closing price.

MarketScreener also lists Nomura's August 24, 2026 decision to maintain a Buy rating while raising its target from USD 22.90 to USD 23.60, MarketScreener shows. The different target levels point to a positive analyst framework, while the October 2 decline keeps the market response measured.

BEKE remains below its yearly high

BEKE's USD 16.44 closing price stood between the 52-week low of USD 13.81 and high of USD 19.88 on October 2, 2026. Its market capitalization was USD 18.2 billion, giving the filing and the earnings beat a clear valuation backdrop.